Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vi...
FDA Drug Recall #D-0242-2021 — Class III — January 11, 2021
Recall Summary
| Recall Number | D-0242-2021 |
| Classification | Class III — Low risk |
| Date Initiated | January 11, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Location | Princeton, NJ |
| Product Type | Drugs |
| Quantity | 36,275 cartons |
Product Description
Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40
Reason for Recall
Incorrect Labeling: Incorrect lot number on secondary packaging
Distribution Pattern
Nationwide
Lot / Code Information
Lot JKX2553A
Other Recalls from SUN PHARMACEUTICAL INDUSTRIES INC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0342-2026 | Class II | Diclofenac Sodium, Topical Gel, 3%, 100 g tube,... | Jan 27, 2026 |
| D-0256-2026 | Class III | Fluocinolone Acetonide Solution Topical Solutio... | Dec 30, 2025 |
| D-0257-2026 | Class III | Clindamycin Phosphate USP, 1% (10 mg/mL), Topic... | Nov 26, 2025 |
| D-0149-2026 | Class II | Lisdexamfetamine Dimesylate Capsules, 60 mg, CI... | Oct 28, 2025 |
| D-0150-2026 | Class II | Lisdexamfetamine Dimesylate Capsules, 70 mg, CI... | Oct 28, 2025 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.